145 related articles for article (PubMed ID: 36787473)
1. Serum C1q/TNF-Related Protein 4 Levels are Associated with Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients.
Han J; Fan H; Dai Y; Cheng X
Metab Syndr Relat Disord; 2023 Apr; 21(3):163-168. PubMed ID: 36787473
[No Abstract] [Full Text] [Related]
2. Association of serum C1Q/TNF-related protein 4 levels with carotid atherosclerosis in subjects with type 2 diabetes mellitus: A cross-sectional study.
Liu Z; Han J; Wang Y; Yang M; Niu L; Shi B
Clin Chim Acta; 2022 Jun; 531():337-341. PubMed ID: 35525266
[TBL] [Abstract][Full Text] [Related]
3. Decreased serum C1Q/TNF-related protein 4 concentrations are associated with type 2 diabetes mellitus.
Liu Z; Lu J; Zhang D; Niu L; Shi B
Ther Adv Endocrinol Metab; 2021; 12():20420188211059884. PubMed ID: 34868546
[TBL] [Abstract][Full Text] [Related]
4. Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Zhang J; Zhang B; Cheng Y; Xu J
Cytokine; 2018 Jun; 106():131-135. PubMed ID: 29113741
[TBL] [Abstract][Full Text] [Related]
5. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
[No Abstract] [Full Text] [Related]
6. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
8. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.
Li YL; Xie H; Musha H; Xing Y; Mei CX; Wang HJ; Wulasihan M
Cell Biochem Biophys; 2015 Jul; 72(3):643-7. PubMed ID: 27352181
[TBL] [Abstract][Full Text] [Related]
9. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease.
Zhang C; Zhou N; Qiu P; Fu Y; Liu Z; Li H; Yang X; Zhang L
Cytokine; 2018 Oct; 110():52-57. PubMed ID: 29704818
[TBL] [Abstract][Full Text] [Related]
10. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
[No Abstract] [Full Text] [Related]
11. Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: An observational study.
Ni L; Yu D; Wu T; Jin F
Medicine (Baltimore); 2021 Feb; 100(6):e24743. PubMed ID: 33578624
[TBL] [Abstract][Full Text] [Related]
12. The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study.
Emamgholipour S; Moradi N; Beigy M; Shabani P; Fadaei R; Poustchi H; Doosti M
Diabetol Metab Syndr; 2015; 7():108. PubMed ID: 26613006
[TBL] [Abstract][Full Text] [Related]
13. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum uric acid level and nonalcoholic fatty liver disease in type 2 diabetes patients.
Yu H; Zhao L; Liu L; Li Y; Sun J; Liu Y
Medicine (Baltimore); 2021 Aug; 100(33):e26946. PubMed ID: 34414956
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in the Association Between AST/ALT and Incidence of Type 2 Diabetes in Japanese Patients with Nonalcoholic Fatty Liver Disease: A Retrospective Cohort Study.
Zhang C; Xu Q; Xu C; Yang K; Xia T; Hasi W; Hao M; Kuang H
Endocr Res; 2024 Jan; 49(1):1-11. PubMed ID: 37752709
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
[TBL] [Abstract][Full Text] [Related]
18. Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts.
Kim J; Lee M; Kim SY; Kim JH; Nam JS; Chun SW; Park SE; Kim KJ; Lee YH; Nam JY; Kang ES
Endocrinol Metab (Seoul); 2021 Aug; 36(4):823-834. PubMed ID: 34474517
[TBL] [Abstract][Full Text] [Related]
19. C1q tumor necrosis factor-related protein 4 is associated with coronary artery disease in patients with type 2 diabetes.
Gao J; Lu J; Qiu J; Sun D; Xu B; Wang Z; Lei T
J Diabetes Investig; 2022 Oct; 13(10):1723-1731. PubMed ID: 35598316
[TBL] [Abstract][Full Text] [Related]
20. Free Triiodothyronine Is Independently Associated with Nonalcoholic Fatty Liver Disease in Hospitalized Type 2 Diabetes Mellitus Patients.
Shi R; Lin C; Hong Y; Xia X; Chen Y; Li S; Xiu L
Biomed Res Int; 2021; 2021():8868339. PubMed ID: 33532498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
